Literature DB >> 29609973

The burden of gunshot wounding of UK military personnel in Iraq and Afghanistan from 2003-14.

T Stevenson1, D J Carr2, J G Penn-Barwell3, T J Ringrose4, S A Stapley5.   

Abstract

INTRODUCTION: Gunshot wounding (GSW) is the second most common mechanism of injury in warfare after explosive injury. The aim of this study was to define the clinical burden of GSW placed on UK forces throughout the recent Iraq and Afghanistan conflicts.
METHODS: This study was a retrospective review of data from the UK Military Joint Theatre Trauma Registry (JTTR). A JTTR search identified records within the 12 year period of conflict between 19 Mar 2003 and 27 Oct 2014 of all UK military GSW casualties sustained during the complete timelines of both conflicts. Included cases had their clinical timelines and treatment further examined from time of injury up until discharge from hospital or death.
RESULTS: There were 723 casualties identified (177 fatalities, 546 survivors). Median age at the time of injury was 24 years (range 18-46 years), with 99.6% of casualties being male. Most common anatomical locations for injury were the extremities, with 52% of all casualties sustaining extremity GSW, followed by 16% GSW to the head, 15% to the thorax, and 7% to the abdomen. In survivors, the rate of extremity injury was higher at 69%, with head, thorax and abdomen injuries relatively lower at 5%, 11% and 6% respectively. All GSW casualties had a total of 2827 separate injuries catalogued. A total of 545 casualties (523 survivors, 22 fatalities) underwent 2357 recorded surgical procedures, which were carried out over 1455 surgical episodes between admission to a deployed medical facility and subsequent transfer to the Royal Centre for Defence Medicine (RCDM) in the UK. This gave a median of 3 (IQR 2-5) surgical procedures within a median of 2 (IQR 2-3) surgical episodes per casualty. Casualties had a combined length of stay (LoS) of 25 years within a medical facility, with a mean LoS in a deployed facility of 1.9 days and 14 days in RCDM.
CONCLUSION: These findings define the massive burden of injury associated with battlefield GSW and underscore the need for further research to both reduce wound incidence and severity of these complex injuries. Crown
Copyright © 2018. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ballistic; Epidemiology; Gunshot; Military; Wounding

Mesh:

Year:  2018        PMID: 29609973     DOI: 10.1016/j.injury.2018.03.028

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  5 in total

1.  Death and long-term disability after gun injury: a cohort analysis.

Authors:  Sheharyar Raza; Deva Thiruchelvam; Donald A Redelmeier
Journal:  CMAJ Open       Date:  2020-07-14

2.  Preliminary effect of projectile yaw on extremity gunshot wounding in a cadaveric animal model: a serendipitous study.

Authors:  Tom Stevenson; Debra J Carr; Iain E Gibb; Sarah A Stapley
Journal:  Int J Legal Med       Date:  2020-03-11       Impact factor: 2.686

3.  The effect of military clothing on gunshot wound patterns in a cadaveric animal limb model.

Authors:  Tom Stevenson; Debra J Carr; Iain E Gibb; Sarah A Stapley
Journal:  Int J Legal Med       Date:  2019-08-14       Impact factor: 2.686

4.  Association between non-acute traumatic injury (TI) and heart rate variability (HRV) in adults: A systematic review protocol.

Authors:  Rabeea Maqsood; Ahmed Khattab; Alexander N Bennett; Christopher J Boos
Journal:  PLoS One       Date:  2022-08-26       Impact factor: 3.752

5.  Injury patterns and causes of death in 953 patients with penetrating abdominal war wounds in a civilian independent non-governmental organization hospital in Lashkargah, Afghanistan.

Authors:  Maurizio Cardi; Khushal Ibrahim; Shah Wali Alizai; Hamayoun Mohammad; Marco Garatti; Antonio Rainone; Francesco Di Marzo; Giuseppe La Torre; Michela Paschetto; Ludovica Carbonari; Valentina Mingarelli; Andrea Mingoli; Giuseppe S Sica; Simone Sibio
Journal:  World J Emerg Surg       Date:  2019-11-21       Impact factor: 5.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.